Avita Medical receives regulatory clearance for Recell Go

Avita Medical (RCEL) announced that Recell Go, its next-generation system for preparing Recell Spray-On Skin, has received certification from Australia’s Therapeutic Goods Administration and has been listed on New Zealand’s Web Assisted Notification of Devices database by Medsafe, enabling commercialization in both markets for burn and acute wound treatment. “The TGA certification and WAND listing of RECELL GO represents an important step in expanding access to RECELL,” said Cary Vance, interim CEO of Avita Medical. “With RECELL GO, we are bringing greater standardization and efficiency to the preparation process, and together with our partner Revolution Surgical, we look forward to supporting adoption across Australia and New Zealand.”